1Department of Medicine, St. Petersburg University, St. Petersburg, Russia
2Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg, Russia
3Department of Pathology, Russian Scientific Center for Radiology and Surgical Technologies, St. Petersburg, Russia
*Corresponding author: Anna Protasova, Department of Medicine, St. Petersburg University, St. Petersburg, Russia, Email: firstname.lastname@example.org
Submission: January 13, 2017; Published: January 23, 2018
ISSN: 2577-2015Volume1 Issue4
Endometrioid borderline tumor (EBT), also known as atypical proliferative endometrioid tumor, accounts for 0.2% of ovarian neoplasmas and 2-3% of borderline ovarian tumors. Very little is known about the prognosis and management of this entity. It is important to correctly diagnose these rare tumors in young women to assure proper treatment and to prevent mortality and preserve fertility.